2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Cohen Alain J | — | 1,804,324 | Apr 5, 2022 |
| Dubin Glenn | — | 790,607 | Apr 2, 2024 |
| Prokupets Elena | Director | 503,126 | Sep 29, 2021 |
| Hirsch Andrew | CEO | 335,300 | Feb 18, 2025 |
| Anderson Kenneth Carl | — | 203,724 | Oct 3, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 18, 2026 | Boyle Scott N | Chief Business Officer | Sell | 91.3 | +190,996 | 177.17% | ✗ | $17K |
| Feb 13, 2026 | Feb 18, 2026 | Mahaney Paige | Chief Scientific Officer | Sell | 90.0 | +237,554 | 239.09% | ✗ | $4.6K |
| Feb 13, 2026 | Feb 18, 2026 | Schick Kelly | Chief People Officer | Sell | 91.3 | +190,996 | 175.41% | ✗ | $17K |
| Feb 13, 2026 | Feb 18, 2026 | Hirsch Andrew | CEO | Sell | 95.0 | +651,789 | 154.03% | ✗ | $91.1K |
| Feb 13, 2026 | Feb 18, 2026 | REYNO LEONARD | Chief Medical Officer | Sell | 91.3 | +223,421 | 142.87% | ✗ | $31.3K |
| Feb 13, 2026 | Feb 18, 2026 | Adams Kendra | CFO | Sell | 91.3 | +222,756 | 137.21% | ✗ | $32.6K |
| Feb 13, 2026 | Feb 18, 2026 | Mossler Mark | Chief Accounting Officer | Sell | 90.0 | +53,712 | 295.06% | ✗ | $6.2K |
| Jan 16, 2026 | Jan 16, 2026 | REYNO LEONARD | Chief Medical Officer | Sell | 26.3 | -10,000 | -6.01% | ✗ | $22.2K |
| Jan 2, 2026 | Jan 5, 2026 | Anderson Kenneth Carl | Director | Neutral | 77.5 | +5,958 | 1.73% | ✗ | - |
| Jan 2, 2026 | Jan 5, 2026 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +7,513 | 12.81% | ✗ | - |
| Oct 28, 2025 | Oct 30, 2025 | Mahaney Paige | Chief Scientific Officer | Sell | 46.3 | -5,644 | -5.38% | ✗ | $14.6K |
| Oct 1, 2025 | Oct 3, 2025 | Anderson Kenneth Carl | Director | Neutral | 77.5 | +5,349 | 1.58% | ✗ | - |
| Oct 1, 2025 | Oct 3, 2025 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +6,740 | 12.99% | ✗ | - |
| Sep 18, 2025 | Sep 19, 2025 | Adams Kendra | CFO | Sell | 47.5 | -2,775 | -1.68% | ✗ | $9.2K |
| Jul 10, 2025 | Jul 15, 2025 | REYNO LEONARD | Chief Medical Officer | Sell | 46.3 | -7,382 | -4.25% | ✗ | $14.7K |
| Jul 10, 2025 | Jul 14, 2025 | REYNO LEONARD | Chief Medical Officer | Sell | 46.3 | -7,382 | -4.25% | ✗ | $14.7K |
| Jul 1, 2025 | Jul 2, 2025 | Anderson Kenneth Carl | Director | Neutral | 77.5 | +7,616 | 2.30% | ✗ | - |
| Jul 1, 2025 | Jul 2, 2025 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +9,609 | 22.73% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Koppikar Utpal | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Hughes Owen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Fawell Stephen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Anderson Kenneth Carl | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Bessen Laura | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | GROGAN DONNA ROY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Cooper Ronald Harold Wilfred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Hoerter Steven L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +9,581 | 29.30% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Anderson Kenneth Carl | Director | Neutral | 77.5 | +7,841 | 2.42% | ✗ | - |
| Feb 14, 2025 | Feb 18, 2025 | Hirsch Andrew | CEO | Sell | 95.0 | +201,283 | 90.72% | ✗ | $70.7K |
| Feb 13, 2025 | Feb 18, 2025 | Siegel Jolie | Chief Legal Officer | Sell | 91.3 | +51,451 | 91.08% | ✗ | $16.1K |
| Feb 13, 2025 | Feb 18, 2025 | Boyle Scott N | Chief Business Officer | Sell | 91.3 | +51,238 | 90.58% | ✓ | $16.7K |
| Feb 14, 2025 | Feb 18, 2025 | Mossler Mark | Chief Accounting Officer | Sell | 47.5 | -1,586 | -8.01% | ✗ | $5K |
| Feb 13, 2025 | Feb 18, 2025 | Schick Kelly | Chief People Officer | Sell | 91.3 | +52,397 | 92.76% | ✗ | $13.1K |
| Feb 13, 2025 | Feb 18, 2025 | Adams Kendra | CFO | Sell | 91.3 | +80,678 | 95.55% | ✗ | $20.5K |
| Feb 14, 2025 | Feb 18, 2025 | Mahaney Paige | Chief Scientific Officer | Neutral | 90.0 | +28,200 | 36.72% | ✗ | - |
| Feb 14, 2025 | Feb 18, 2025 | REYNO LEONARD | Chief Medical Officer | Sell | 91.3 | +81,955 | 89.27% | ✗ | $16.4K |
| Jan 2, 2025 | Jan 3, 2025 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +3,757 | 12.98% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Anderson Kenneth Carl | Director | Neutral | 67.5 | +3,074 | 0.96% | ✗ | - |
| Nov 19, 2024 | Nov 21, 2024 | Hoerter Steven L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2024 | Hoerter Steven L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 7, 2024 | Nov 12, 2024 | Boyle Scott N | Chief Business Officer | Sell | 47.5 | -1,102 | -1.91% | ✗ | $6.7K |
| Nov 7, 2024 | Nov 12, 2024 | Adams Kendra | CFO | Sell | 47.5 | -1,102 | -1.29% | ✗ | $6.7K |
| Nov 7, 2024 | Nov 12, 2024 | Schick Kelly | Chief People Officer | Sell | 47.5 | -1,102 | -1.91% | ✗ | $6.7K |
| Nov 7, 2024 | Nov 12, 2024 | Siegel Jolie | Chief Legal Officer | Sell | 47.5 | -1,102 | -1.91% | ✗ | $6.7K |
| Nov 7, 2024 | Nov 12, 2024 | Hirsch Andrew | CEO | Sell | 46.3 | -5,550 | -2.44% | ✗ | $33.5K |
| Oct 28, 2024 | Oct 29, 2024 | Mahaney Paige | Chief Scientific Officer | Neutral | 90.0 | +76,800 | 100.00% | ✗ | - |
| Oct 29, 2024 | Mahaney Paige | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 1, 2024 | Oct 2, 2024 | GROGAN DONNA ROY | Director | Neutral | 85.0 | +2,474 | 9.35% | ✗ | - |
| Oct 1, 2024 | Oct 2, 2024 | Anderson Kenneth Carl | Director | Neutral | 67.5 | +2,023 | 0.64% | ✗ | - |
| Sep 18, 2024 | Sep 20, 2024 | Adams Kendra | CFO | Sell | 46.3 | -1,837 | -2.20% | ✗ | $11.7K |
| Sep 16, 2024 | Sep 17, 2024 | Hirsch Andrew | CEO | Sell | 46.3 | -3,329 | -1.53% | ✗ | $21.2K |
| Sep 16, 2024 | Sep 17, 2024 | Boyle Scott N | Chief Business Officer | Sell | 47.5 | -661 | -1.21% | ✗ | $4.2K |
| Sep 16, 2024 | Sep 17, 2024 | Adams Kendra | CFO | Sell | 50.0 | -661 | -0.78% | ✗ | $4.2K |
| Sep 16, 2024 | Sep 17, 2024 | Fisher Stewart | Chief Scientific Officer | Sell | 50.0 | -661 | -0.50% | ✗ | $4.2K |
| Sep 16, 2024 | Sep 17, 2024 | Schick Kelly | Chief People Officer | Sell | 47.5 | -661 | -1.21% | ✗ | $4.2K |
| Sep 16, 2024 | Sep 17, 2024 | Siegel Jolie | Chief Legal Officer | Sell | 47.5 | -661 | -1.21% | ✗ | $4.2K |
| Aug 29, 2024 | Sep 3, 2024 | Fawell Stephen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 3, 2024 | Fawell Stephen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 10, 2024 | Jul 11, 2024 | REYNO LEONARD | Chief Medical Officer | Sell | 46.3 | -6,191 | -6.32% | ✗ | $31K |
| Jul 1, 2024 | Jul 2, 2024 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +2,836 | 12.00% | ✗ | - |
| Jul 1, 2024 | Jul 2, 2024 | Anderson Kenneth Carl | Director | Neutral | 67.5 | +2,320 | 0.73% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Hughes Owen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Bessen Laura | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Koppikar Utpal | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | DOWNEY BRUCE | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Salter Malcolm | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Anderson Kenneth Carl | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | GROGAN DONNA ROY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 7, 2024 | Jun 11, 2024 | Cooper Ronald Harold Wilfred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2024 | Cooper Ronald Harold Wilfred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 14, 2024 | Apr 10, 2024 | Mossler Mark | Chief Accounting Officer | Neutral | 90.0 | +18,290 | 1219.33% | ✗ | - |
| Apr 1, 2024 | Apr 2, 2024 | Anderson Kenneth Carl | Director | Neutral | 60.0 | +1,389 | 0.44% | ✗ | - |
| Apr 1, 2024 | Apr 2, 2024 | Dubin Glenn | Director | Neutral | 55.0 | +1,358 | 0.17% | ✗ | - |
| Apr 1, 2024 | Apr 2, 2024 | GROGAN DONNA ROY | Director | Neutral | 85.0 | +1,697 | 7.74% | ✗ | - |
| Mar 7, 2024 | Mar 8, 2024 | Boyle Scott N | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 8, 2024 | Fisher Stewart | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 8, 2024 | Schick Kelly | Chief People Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 8, 2024 | Adams Kendra | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 8, 2024 | Siegel Jolie | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Feb 15, 2024 | Hirsch Andrew | CEO | Sell | 42.5 | -6,560 | -3.02% | ✗ | $51.8K |
| Feb 14, 2024 | Feb 15, 2024 | Hirsch Andrew | CEO | Neutral | 90.0 | +103,400 | 90.78% | ✗ | - |
| Feb 14, 2024 | Feb 15, 2024 | REYNO LEONARD | Chief Medical Officer | Neutral | 90.0 | +36,700 | 59.87% | ✗ | - |
| Feb 13, 2024 | Feb 15, 2024 | Siegel Jolie | Chief Legal Officer | Sell | 91.3 | +25,565 | 95.80% | ✗ | $11.3K |
| Feb 13, 2024 | Feb 15, 2024 | Schick Kelly | Chief People Officer | Sell | 91.3 | +25,565 | 95.80% | ✗ | $11.3K |
| Feb 13, 2024 | Feb 15, 2024 | Fisher Stewart | Chief Scientific Officer | Sell | 91.3 | +25,045 | 24.06% | ✗ | $14.7K |
| Feb 13, 2024 | Feb 15, 2024 | Boyle Scott N | Chief Business Officer | Sell | 91.3 | +25,565 | 95.52% | ✗ | $11.3K |
| Feb 13, 2024 | Feb 15, 2024 | Adams Kendra | CFO | Sell | 90.0 | +35,399 | 75.90% | ✗ | $8.5K |
| Jan 2, 2024 | Jan 3, 2024 | Dubin Glenn | Director | Neutral | 60.0 | +1,687 | 0.21% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | Anderson Kenneth Carl | Director | Neutral | 67.5 | +1,725 | 0.55% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +2,108 | 10.63% | ✗ | - |
| Nov 16, 2023 | Nov 20, 2023 | Hughes Owen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 20, 2023 | Hughes Owen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 2, 2023 | Oct 3, 2023 | Anderson Kenneth Carl | Director | Neutral | 77.5 | +6,617 | 2.16% | ✗ | - |
| Oct 2, 2023 | Oct 3, 2023 | Dubin Glenn | Director | Neutral | 67.5 | +6,470 | 0.81% | ✗ | - |
| Oct 2, 2023 | Oct 3, 2023 | GROGAN DONNA ROY | Director | Neutral | 90.0 | +8,089 | 68.91% | ✗ | - |
| Sep 18, 2023 | Sep 19, 2023 | Hirsch Andrew | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 18, 2023 | Sep 19, 2023 | Schick Kelly | Chief People Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 18, 2023 | Sep 19, 2023 | Fisher Stewart | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 18, 2023 | Sep 19, 2023 | Boyle Scott N | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 18, 2023 | Sep 19, 2023 | Siegel Jolie | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |